USANA Health Sciences (NYSE:USNA) Shares Down 2.1% After Insider Selling

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price was down 2.1% on Friday after an insider sold shares in the company. The company traded as low as $29.79 and last traded at $29.73. Approximately 10,077 shares were traded during trading, a decline of 90% from the average daily volume of 100,948 shares. The stock had previously closed at $30.37.

Specifically, insider Joshua Foukas sold 5,732 shares of the firm’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total value of $186,519.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider David Mulham Mulham sold 3,234 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $32.98, for a total value of $106,657.32. Following the completion of the sale, the insider now directly owns 12,775 shares in the company, valued at $421,319.50. This trade represents a 20.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analyst Ratings Changes

Several analysts recently weighed in on the company. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. DA Davidson dropped their target price on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research report on Thursday, February 27th. Finally, Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

USANA Health Sciences Price Performance

The stock has a market capitalization of $548.91 million, a P/E ratio of 10.26, a P/E/G ratio of 0.93 and a beta of 0.98. The firm has a 50-day simple moving average of $32.53 and a 200 day simple moving average of $35.90.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15. The business had revenue of $213.61 million during the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On USANA Health Sciences

Hedge funds have recently added to or reduced their stakes in the company. R Squared Ltd acquired a new stake in USANA Health Sciences in the fourth quarter valued at approximately $28,000. Safe Harbor Fiduciary LLC purchased a new position in shares of USANA Health Sciences during the third quarter valued at approximately $30,000. KBC Group NV boosted its position in shares of USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after buying an additional 519 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of USANA Health Sciences during the fourth quarter valued at approximately $83,000. Finally, Quantbot Technologies LP bought a new stake in USANA Health Sciences during the fourth quarter worth $132,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.